Alphatec Holdings, Inc. (ATEC)

Market Cap	1.49B
Revenue (ttm)	611.56M
Net Income (ttm)	-162.12M
Shares Out	144.15M
EPS (ttm)	-1.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,150,502
Open	10.35
Previous Close	10.49
Day's Range	10.17 - 10.57
52-Week Range	4.88 - 14.54
Beta	1.39
Analysts	Strong Buy
Price Target	17.60 (+70.54%)
Earnings Date	May 6, 2025

About ATEC

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 2, 2006
• Employees: 867
• Stock Exchange: NASDAQ
• Ticker Symbol: ATEC
• Website: https://www.atecspine.com

Financial Performance

In 2024, Alphatec Holdings's revenue was $611.56 million, an increase of 26.81% compared to the previous year's $482.26 million. Losses were -$162.12 million, -13.14% less than in 2023.

Analyst Forecast

According to 10 analysts, the average rating for ATEC stock is "Strong Buy." The 12-month stock price forecast is $17.6, which is an increase of 70.54% from the latest price.

Price Target

$17.6

(70.54% upside)

Analyst Consensus: Strong Buy